Respiratory infections
Session
Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
Clinical
Results of the ERS/ESCIM/ESCMID/ALAT Guidelines
Aims : To review in depth the current epidemiology of HAP and VAP
To review in perspective and give new insights about the diagnosis of HAP/VAP
To show the new International ERS/ESCIM/ECCMID/ALAT recommendations
To discuss antibiotic treatment of HAP/VAP beyond guidelines including new options
Target audience :
Anaesthesiologist, Clinician, Epidemiologist, Intensivist/critical care physician, Junior member, Microbiologist, Pulmonologist, Researcher, Respiratory physician, Scientist
08:30
Epidemiology of HAP/VAP: The real burden
I. Martin-Loeches(Dublin, Ireland)
COI
1
1741
09:00
Diagnosis of HAP/VAP today
J. Chastre(Paris, France)
COI
2
1742
09:30
International Recommendations for HAP and VAP
A. Torres Marti(Barcelona, Spain)
COI
3
1743
10:00
Antibiotic treatment considerations beyond guidelines
M. Niederman(New York, United States)
COI
4
1744
. . .
